Hanna Myhrman - ADDvise Group G Counsel
| ADDV-B Stock | SEK 3.78 0.19 5.29% |
Insider
Hanna Myhrman is G Counsel of ADDvise Group B
| Age | 31 |
| Phone | 46 8 12 87 66 00 |
| Web | https://www.addvisegroup.se |
ADDvise Group Management Efficiency
The company has return on total asset (ROA) of 0.0471 % which means that it generated a profit of $0.0471 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1503 %, meaning that it generated $0.1503 on every $100 dollars invested by stockholders. ADDvise Group's management efficiency ratios could be used to measure how well ADDvise Group manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Anders Goransson | Bactiguard Holding AB | 52 | |
| Patrick Jamnik | Episurf Medical AB | 40 | |
| Andreas MD | Xvivo Perfusion AB | 46 | |
| Fredrik Zetterberg | Episurf Medical AB | 48 | |
| Beata Lihammar | Episurf Medical AB | N/A | |
| Carl Fredin | Bactiguard Holding AB | 57 | |
| Erica Bell | BICO Group AB | 50 | |
| Michael Nsstrm | Episurf Medical AB | 34 | |
| Lotta Bus | BICO Group AB | 53 | |
| Niklas Carln | Stille AB | 49 | |
| Johan Folkunger | SpectraCure AB | 55 | |
| Carin Jakobson | Bactiguard Holding AB | 49 | |
| Asa Hillsten | BICO Group AB | 48 | |
| Hanna Wilkman | Stille AB | 56 | |
| Kristina Holst | SpectraCure AB | N/A | |
| Pal Ryfors | Episurf Medical AB | 40 | |
| Charlotte Walldal | Xvivo Perfusion AB | 56 | |
| Sathish Subramaniam | Bactiguard Holding AB | 44 | |
| Mirjam Johansson | SpectraCure AB | N/A | |
| Jason Clifton | BICO Group AB | N/A | |
| Peter Radqvist | Bactiguard Holding AB | 56 | |
Management Performance
| Return On Equity | 0.15 | |||
| Return On Asset | 0.0471 |
ADDvise Group B Leadership Team
Elected by the shareholders, the ADDvise Group's board of directors comprises two types of representatives: ADDvise Group inside directors who are chosen from within the company, and outside directors, selected externally and held independent of ADDvise. The board's role is to monitor ADDvise Group's management team and ensure that shareholders' interests are well served. ADDvise Group's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, ADDvise Group's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Johan Eklund, Chief Auditor | ||
| Fredrik Mella, Chief Officer | ||
| Hanna Myhrman, G Counsel | ||
| Astrid Mller, Head Service | ||
| Nils Berglund, VP | ||
| Sebastian Robson, Chief Officer | ||
| Mats Andersson, Sales Ventilation | ||
| Richard Akhtarzand, CEO Pres |
ADDvise Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is ADDvise Group a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.15 | |||
| Return On Asset | 0.0471 | |||
| Profit Margin | 0.07 % | |||
| Operating Margin | 0.11 % | |||
| Current Valuation | 1.76 B | |||
| Shares Outstanding | 172.87 M | |||
| Shares Owned By Insiders | 53.10 % | |||
| Shares Owned By Institutions | 26.44 % | |||
| Price To Book | 2.70 X | |||
| Price To Sales | 1.62 X |
Thematic Opportunities
Explore Investment Opportunities
Other Information on Investing in ADDvise Stock
ADDvise Group financial ratios help investors to determine whether ADDvise Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in ADDvise with respect to the benefits of owning ADDvise Group security.